NCT00080080 2007-06-08
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
Point Therapeutics
Phase 2 Completed
Clinical Trials
3 trialsNCT00083239 2007-06-08
Study of Talabostat in Advanced Melanoma
Point Therapeutics
Phase 2 Completed
NCT00290017 2007-06-08
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
Point Therapeutics
Phase 3 Terminated